-
December
If governments insist in central clearing for illiquid contracts, they must accept the consequences.
-
How new European regulations will lead to both increased competition and increased data requirements in exchange traded derivatives.
-
November
Financial institutions should take action now to prepare for new OTC regulations.
-
The buy-side say there is a case for exempting them from the obligation to centrally clear OTC derivatives trades. Now the dealers are backing them finds Dan Barnes.
-
Research suggests that central counterparties do not have the capacity to deal with the increase in volume of OTC derivatives processing that Dodd-Frank and EMIR will bring. Dan Barnes looked at what they were doing to meet demand.
-
Why exchange owned clearing houses are the best model.
-
October
Asset managers are assessing the best way to manage the increased collateral obligations for OTC derivatives trades that will be required by new post-trade regulations pending in the US and Europe. However, incomplete regulation is hampering their ability to assess the suitability of systems on offer, finds Dan Barnes.
-
Regulatory reform in the OTC derivatives market will force changes in the way firms manage their collateral exposures, leaving participants concerned about the increasing complexity of the market.
-
September
What are the implications for European market structure of LSE's bid for LCH.Clearnet.
-
While the London Stock Exchange’s bid for LCH.Clearnet makes commercial sense, it opens up the exchange to charges of hypocrisy.
-
July
Make no mistake, the 2009 G20 leaders statement on OTC derivatives will be seen to have been the initiator of a revolution in OTC derivatives trading as we know it today.
-
May
Exchange ownership of the intellectual property of derivative contracts is a barrier to competition, the chief executive of the London Stock Exchange claimed today.
-
Nasdaq OMX and Intercontinental Exchange’s hostile bid has disrupted what was supposed to be a smooth and amicable deal to merge Deutsche Börse with NYSE Euronext. It has also raised questions over the long term viability of the vertical silo clearing model on both sides of the Atlantic. William Mitting examines the implications of the takeover battle and how the clearing issue has come to the fore.
-
The London Metal Exchange is giving “serious consideration to the possibility of building its own clearing house” in a blow to incumbent LCH.Clearnet.
-
April
The US Commodity Futures Trading Commission and the Securities and Exchange Commission voted yesterday to approve proposed rules defining a swap.
-
A report by the Financial Stability Board on the progress of OTC derivatives market reform has found significant differences in implementation across G-20 nations and raised fears that some will not meet the December 2012 deadline for reform.
-
New York Portfolio Clearing, the derivatives clearing house backed by NYSE Liffe and the Depository Trust and Clearing Corp, has elected Bernie Dan, former head of the Chicago Board of Trade and MF Global, as an independent member of its board of directors.
-
February
-
-
-
-
-
For decades clearing houses have provided a stable, safe service to the futures and options market. Now, the contours of the market are about to change. Large tracts of the over the counter market may be opened up for clearing, leading to a land grab by existing players and new entrants. As competition intensifies, the big clearing houses face as many risks as opportunities. And, as David Wigan discovers, the next two years of upheaval and debate could bring the market closer to a transparent and accurate calculation of the costs and benefits of clearing.
-
-
The EU’s efforts to tighten regulation of over-the-counter derivatives are entering a crucial stage. Decisions in the next few months will affect the market for years to come. Pauline Ashall and Mark Middleton, partners at Linklaters, highlight the essential issues that remain to be decided.
-
Hong Kong Exchanges and Clearing will launch an over-the-counter derivatives clearing house in late 2012, subject to regulatory approval.
-
-
-
Corporate hedgers are battling against mandatory clearing for OTC derivatives. Why? asks Philip McBride Johnson. The costs are modest and the benefits compelling.